[{"Assets_0_Q1_USD":9727200000.0,"CommonStockSharesConverted_0_Q1_shares":398825969.0,"CommonStockSharesOutstanding_0_Q1_shares":398825969.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":4300000.0,"NetIncomeLossConverted_1_Q1_USD":-49100000.0,"StockholdersEquity_0_Q1_USD":6661500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":403900000.0,"EarningsPerShareBasic_1_Q1_USD":-0.12,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":403900000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.12,"RevenuesConverted_1_Q1_USD":657700000.0,"Ticker":"ELAN","CIK":"1739104","name":"ELANCO ANIMAL HEALTH INC","OfficialName":"Elanco Animal Health Incorporated Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"12367077748.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20200507"}]